Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area
Tavoschi, L., Mason, L., Petriti, U., Bunge, E., Veldhuijzen, I., Duffell, E.
Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review
Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.
Hepatitis B/C in the countries of the EU/EEA: A systematic review of the prevalence among at-risk groups
Falla, A.M., Hofstraat, S.H.I., Duffell, E., Hahné, S.J.M., Tavoschi, L., Veldhuijzen, I.K.
Travel-associated hepatitis A in Europe, 2009 to 2015
Beauté, J., Westrell, T., Schmid, D., Müller, L., Epstein, J., Kontio, M., Couturier, E., Faber, M., Mellou, K., Borg, M.-L., Friesema, I., Vold, L., Severi, E.
Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries
Ahmad, A.A., Falla, A.M., Duffell, E., Noori, T., Bechini, A., Reintjes, R., Veldhuijzen, I.K.
Multistate foodborne hepatitis A outbreak among European tourists returning from Egypt-need for reinforced vaccination recommendations, November 2012 to April 2013
Sane, J., Macdonald, E., Vold, L., Gossner, C., Severi, E.
Three simultaneous, Food-borne, Multi-country outbreaks of hepatitis A virus infection reported in EPIS-FWD in 2013: What does it mean for the European Union?
Gossner, C.M., Severi, E.
ECDC Vaccine Scheduler
The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups.
- Hepatitis A
- Hepatitis B
- Human papillomavirus infection
- Influenza in humans, seasonal
- Invasive Haemophilus influenzae disease
- Meningococcal disease
- Pneumococcal disease
- Prevention and control
- Rotavirus infection
- Tick-borne diseases
Hepatitis A Seroprevalence in a population of immigrants at a French vaccination centreArchived
The authors retrospectively analyzed hepatitis A virus (HAV) seroprevalence in travellers who had been born and lived at least 1 year in a developing country, wanted to travel to a hepatitis A endemic area, and consulted at the vaccination centre of the Institut Pasteur of Paris between September 1, 2008 and February 28, 2010. HAV seroprevalence was 82.4 % for a population of 646 immigrants for whom data were available